Pathway Genomics welcomed strategic partner IBM Watson to its customer base in a round that lifted its overall funding to more than $130m.
Month: January 2016
Ahmad hitches a ride on Hyundai
Salmaun Ahmad, formerly a business development manager at Disney, has taken on a role at Hyundai’s Silicon Valley strategic innovation office.
Aver savours $13.6m for series B
Healthcare reimbursement data platform Aver took its total funding to almost $25m in a round featuring Hearst and existing investor General Electric.
Primarc sets out corporate venturing plans
Primarc iVenture will invest up to $150,000 in West Bengal startups developing ideas that are unique or which have the potential for social impact.
Qufenqi to join IPO queue as it raises new funding
Existing investor Kunlun Tech has provided $27m for the round, which the instalment buying platform is raising as it gets ready for a flotation in China.
Ford and DJI launch $100,000 drone challenge
The two companies are asking startups to create drone-to-vehicle communications technology that could be used by the UN to conduct search and rescue missions.
UTour boards Qyer in $60m series D
Travel agency UTour has led a fourth funding round for the Alibaba-backed travel and tourism website by purchasing both new and existing shares.
Merck-backed Visterra targets $69m in IPO
The antibody-based drug developer has raised $77m in financing, with Merck leading its $30m series B round in 2014.
Legend pours $61m into Liquor Easy
Liquor Easy offers express delivery of alcoholic drinks to consumers and will use the cash to expand further across China.
Flatiron Health warms up with $175m
The oncology platform provider, previously backed by Alphabet and LabCorp, has secured $175m in a round led by strategic partner Roche.
Spire stretches to new heights with $40m
The Mitsui and Qihoo 360-backed nanosatellite company took its overall funding past $80m with a Promus Ventures-led series B round.
2016 outlook: communications access and applications
On Monday and Tuesday, in the first part and second part of this outlook in Global Corporate Venturing, we covered genome editing tools that could change life and their progeny, a possible future evolution of computing to support artificial intelligence through quantum computing and fuelling the mind and body through virtual reality and improved food… Continue reading 2016 outlook: communications access and applications
Blaustein bids farewell to DuPont
Managing director of its corporate venturing unit since 2006, Michael Blaustein is leaving chemicals producer DuPont and retiring at the end of this quarter.
Roche helps treat Millendo to $62m
Millendo has received series B funding from investors including Roche, while AstraZeneca acquired a stake in the biopharmaceutical company through a licensing deal.